Gilead Sciences, Inc.
United States of America (USA)
1 December 2019 - 30 November 2020
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Gilead Sciences, Inc. published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
15 | 4.58 |
Outputs by subject (Share)
Subject | Count | Share | |
---|---|---|---|
Life Sciences | 15 | 4.58 | |
Chemistry | 1 | 0.92 | |
Physical Sciences | 1 | 0.92 | |
Nature | 1 | 0.92 |
Top articles by Altmetric score in current window
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
Proceedings of the National Academy of Sciences of the United States of America
2020-02-13
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Nature Communications
2020-01-10
The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus
Journal of Biological Chemistry
2020-02-24
1 December 2019 - 30 November 2020
International vs. domestic collaboration by Share
- 76.11% Domestic
- 23.89% International
Note: Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators by Share (25 total)
- Gilead Sciences, Inc., United States of America (USA)
- Domestic institution
-
National Institutes of Health (NIH), United States of America (USA)
(3.52)
-
University of Texas Medical Branch (UTMB), United States of America (USA)
(1.91)
-
The University of North Carolina at Chapel Hill (UNC), United States of America (USA)
(0.95)
-
Prism Health North Texas, United States of America (USA)
(0.93)
-
Texas Centers for Infectious Disease Associates (TCIDA), United States of America (USA)
(0.93)
-
Ruane Clinical Research Group Inc., United States of America (USA)
(0.93)
-
The University of Utah (Utah), United States of America (USA)
(0.93)
-
Harbor-UCLA Medical Center, United States of America (USA)
(0.93)
-
Gordon E. Crofoot MD, PA, United States of America (USA)
(0.93)
-
University of California, Los Angeles (UCLA), United States of America (USA)
(0.92)
Top 10 international collaborators by Share (8 total)
- Gilead Sciences, Inc., United States of America (USA)
- Foreign institution
-
University of Alberta (U of A), Canada
(3.39)
-
Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Italy
(0.90)
-
F. Hoffmann-La Roche AG, Switzerland
(0.79)
-
Hiroshima University (HU), Japan
(0.36)
-
Goethe University Frankfurt (GU), Germany
(0.24)
-
Japanese Red Cross Society, Japan
(0.19)
-
Sapporo Kosei General Hospital, Japan
(0.19)
-
National Taiwan University (NTU), Taiwan
(0.19)
Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.
Affiliated joint institutions and consortia

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.